Table 2.
Response of study participants to chloroquine drug during 28 days follow-up in Halaba Kulite Health Center, South Ethiopia, January 2009.
| Follow-up period |
At Risk | Excluded from the study for different reasons |
Treatment failure |
Survival Probability Estimate |
0.95 Confidence Interval |
|
|---|---|---|---|---|---|---|
| Lower Limit |
Upper Limit |
|||||
| Day 0 | 87 | 0 | 0 | 1 | 0.9473 | 1 |
| Day 1 | 87 | 4 | 0 | 1 | 0.9473 | 1 |
| Day 2 | 84 | 0 | 0 | 1 | 0.9473 | 1 |
| Day 3 | 83 | 2 | 0 | 1 | 0.9473 | 1 |
| Day 7 | 81 | 0 | 4 | 0.9506 | 0.8755 | 0.9833 |
| Day 14 | 72 | 0 | 6 | 0.8714 | 0.7784 | 0.9305 |
| Day 21 | 60 | 1 | 1 | 0.8569 | 0.7617 | 0.9197 |
| Day 28 | 58 | 0 | 0 | 0.8569 | 0.7616 | 0.9197 |